183 related articles for article (PubMed ID: 8740360)
21. N-Aryl sulfonyl homocysteine hydroxamate inhibitors of matrix metalloproteinases: further probing of the S(1), S(1)', and S(2)' pockets.
Hanessian S; Moitessier N; Gauchet C; Viau M
J Med Chem; 2001 Sep; 44(19):3066-73. PubMed ID: 11543675
[TBL] [Abstract][Full Text] [Related]
22. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.
Moy FJ; Chanda PK; Chen JM; Cosmi S; Edris W; Levin JI; Powers R
J Mol Biol; 2000 Sep; 302(3):671-89. PubMed ID: 10986126
[TBL] [Abstract][Full Text] [Related]
23. Stromelysin-1: three-dimensional structure of the inhibited catalytic domain and of the C-truncated proenzyme.
Becker JW; Marcy AI; Rokosz LL; Axel MG; Burbaum JJ; Fitzgerald PM; Cameron PM; Esser CK; Hagmann WK; Hermes JD
Protein Sci; 1995 Oct; 4(10):1966-76. PubMed ID: 8535233
[TBL] [Abstract][Full Text] [Related]
24. Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitor.
Lovejoy B; Cleasby A; Hassell AM; Longley K; Luther MA; Weigl D; McGeehan G; McElroy AB; Drewry D; Lambert MH
Science; 1994 Jan; 263(5145):375-7. PubMed ID: 8278810
[TBL] [Abstract][Full Text] [Related]
25. Matrix metalloproteinase inhibitors: a review on pharmacophore mapping and (Q)SARs results.
Kontogiorgis CA; Papaioannou P; Hadjipavlou-Litina DJ
Curr Med Chem; 2005; 12(3):339-55. PubMed ID: 15723623
[TBL] [Abstract][Full Text] [Related]
26. Dynamics of stromelysin/inhibitor interactions studied by 15N NMR relaxation measurements: comparison of ligand binding to the S1-S3 and S'1-S'3 subsites.
Yuan P; Marshall VP; Petzold GL; Poorman RA; Stockman BJ
J Biomol NMR; 1999 Sep; 15(1):55-64. PubMed ID: 10549133
[TBL] [Abstract][Full Text] [Related]
27. NMR solution structure of the catalytic fragment of human fibroblast collagenase complexed with a sulfonamide derivative of a hydroxamic acid compound.
Moy FJ; Chanda PK; Chen JM; Cosmi S; Edris W; Skotnicki JS; Wilhelm J; Powers R
Biochemistry; 1999 Jun; 38(22):7085-96. PubMed ID: 10353819
[TBL] [Abstract][Full Text] [Related]
28. Bioactive conformation of stromelysin inhibitors determined by transferred nuclear Overhauser effects.
Gonnella NC; Bohacek R; Zhang X; Kolossváry I; Paris CG; Melton R; Winter C; Hu SI; Ganu V
Proc Natl Acad Sci U S A; 1995 Jan; 92(2):462-6. PubMed ID: 7831311
[TBL] [Abstract][Full Text] [Related]
29. Resonance assignments for stromelysin complexed with a beta-sulfonyl hydroxamate inhibitor.
Sahasrabudhe PV; Stockman BJ
Biomol NMR Assign; 2009 Dec; 3(2):183-6. PubMed ID: 19888686
[TBL] [Abstract][Full Text] [Related]
30. The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity.
Bode W; Reinemer P; Huber R; Kleine T; Schnierer S; Tschesche H
EMBO J; 1994 Mar; 13(6):1263-9. PubMed ID: 8137810
[TBL] [Abstract][Full Text] [Related]
31. Matrilysin-inhibitor complexes: common themes among metalloproteases.
Browner MF; Smith WW; Castelhano AL
Biochemistry; 1995 May; 34(20):6602-10. PubMed ID: 7756291
[TBL] [Abstract][Full Text] [Related]
32. Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor.
Rowsell S; Hawtin P; Minshull CA; Jepson H; Brockbank SM; Barratt DG; Slater AM; McPheat WL; Waterson D; Henney AM; Pauptit RA
J Mol Biol; 2002 May; 319(1):173-81. PubMed ID: 12051944
[TBL] [Abstract][Full Text] [Related]
33. Structure of recombinant mouse collagenase-3 (MMP-13).
Botos I; Meyer E; Swanson SM; Lemaître V; Eeckhout Y; Meyer EF
J Mol Biol; 1999 Oct; 292(4):837-44. PubMed ID: 10525409
[TBL] [Abstract][Full Text] [Related]
34. Structure of human neutrophil collagenase reveals large S1' specificity pocket.
Stams T; Spurlino JC; Smith DL; Wahl RC; Ho TF; Qoronfleh MW; Banks TM; Rubin B
Nat Struct Biol; 1994 Feb; 1(2):119-23. PubMed ID: 7656015
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the structure of human recombinant short form stromelysin by multidimensional heteronuclear NMR and X-ray crystallography.
Gooley PR; O'Connell JF; Marcy AI; Cuca GC; Axel MG; Caldwell CG; Hagmann WK; Becker JW
J Biomol NMR; 1996 Jan; 7(1):8-28. PubMed ID: 8720828
[TBL] [Abstract][Full Text] [Related]
36. Catalytic mechanism of matrix metalloproteinases: two-layered ONIOM study.
Pelmenschikov V; Siegbahn PE
Inorg Chem; 2002 Nov; 41(22):5659-66. PubMed ID: 12401069
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the binding of hydroxamic acid and carboxylic acid inhibitors to the stromelysin-1 (matrix metalloproteinase-3) catalytic domain by isothermal titration calorimetry.
Parker MH; Lunney EA; Ortwine DF; Pavlovsky AG; Humblet C; Brouillette CG
Biochemistry; 1999 Oct; 38(41):13592-601. PubMed ID: 10521266
[TBL] [Abstract][Full Text] [Related]
38. Structural basis for the highly selective inhibition of MMP-13.
Engel CK; Pirard B; Schimanski S; Kirsch R; Habermann J; Klingler O; Schlotte V; Weithmann KU; Wendt KU
Chem Biol; 2005 Feb; 12(2):181-9. PubMed ID: 15734645
[TBL] [Abstract][Full Text] [Related]
39. Design and synthesis of matrix metalloproteinase inhibitors guided by molecular modeling. Picking the S(1) pocket using conformationally constrained inhibitors.
Hanessian S; MacKay DB; Moitessier N
J Med Chem; 2001 Sep; 44(19):3074-82. PubMed ID: 11543676
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1.
Gomis-Rüth FX; Maskos K; Betz M; Bergner A; Huber R; Suzuki K; Yoshida N; Nagase H; Brew K; Bourenkov GP; Bartunik H; Bode W
Nature; 1997 Sep; 389(6646):77-81. PubMed ID: 9288970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
